Brain Tumor Research
The
Heroes of Hope Grey Ribbon Crusade joins organizations and individuals
as one united force against brain tumors.
The group provides support for those affected by the disease and serves as a hub, allowing people to gather information and share resources, while providing a vehicle for fundraising. The union offers a unique opportunity to place increased hope on the horizon, by gaining knowledge of, discussing and funding prospective research projects that may soon lead to a cure. Many of these projects require immediate funding. IF you are a researcher looking for funding for a brain tumor research project, go to our MEMBERS list and contact one member - and pitch your idea to them. IF they like it, they will ask you to fill out an application and then propose it to the group for you! There are no deadline. We accept applications year round, get our board to approve them quickly, THEN work together here to find funding for projects that interest us.
Research that is waiting to be funded:
 |
STUDY | |
 |
|
DATE PROPOSED & AMOUNT | |
|
|
SPONSORING MEMBERS |
|
Assessment of FDA approved drugs in high quality models of pediatric brainstem gliomas | |
|
|
03/12/2011 $20,000.00 |
|
|
|
|
|
|||||||||
|
Proton Radiosurgery Following Radiation Therapy in cerebral Glioblastoma Multiforme | |
|
|
12/07/2009 $25,000.00 |
|
|
|
|
|
|||||||||
|
Therapeutic modulation of the methyl-CpG-binding domain protein 2 (MBD2) in glioma | |
|
|
09/21/2009 $200,000.00 |
|
|
|
|
|
|||||||||
|
Elucidating the Mechanism of the anti-angiogenic function of CDKN2A/p14ARF in Glioma | |
|
|
09/21/2009 $200,000.00 |
|
|
|
|
|
|||||||||
|
Radiosensitization of medulloblastoma by altering the intracellular redox environment with microRNA 128a | |
|
|
08/26/2009 $65,000.00 |
|
|
|
|
|
|||||||||
|
Dendriatic Cell Vaccine Trial Expansion to Pediatrics | |
|
|
11/24/2008 $200,000.00 Partially funded: $69,000.00 |
|
|
|
|
|
|||||||||
|
Survivor Stories | |
|
|
06/18/2008 $30,000.00 |
|
|
|
|
|
|||||||||
|
Analysis Of Out-Of-Pocket Costs Of Care And Quality Of Life Concordance For Patients With Malignant Gliomas And Their Caregivers. | |
|
|
05/26/2008 $55,000.00 |
|
|
|
|
|
|||||||||
Research that we have funded:
|
STUDY | |
|
|
DATE FUNDED & AMOUNT | |
|
|
SPONSORING MEMBERS |
|
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG | |
|
|
12/01/2011 $229,000.00 |
|
|
|
|
|
|||||||||
|
Novel Approaches To Target Gliomas – IDH1 and IDH2 Mutations in Gliomas | |
|
|
10/01/2011 $1,000,000.00 |
|
|
|
|
|
|||||||||
|
Dendritic Cell Vaccine for Low-Grade Glioma Patients Trial | |
|
|
06/01/2011 $100,000.00 |
|
|
|
|
|
|||||||||
|
Heavy Ion Microbeam Radiation Therapy of High Grade Gliomas | |
|
|
07/21/2010 $25,000.00 |
|
|
|
|
|
|||||||||
|
In vivo prioritization of FDA drugs for PNET brain tumors. | |
|
|
07/21/2010 $38,025.00 |
|
|
|
|
|
|||||||||
|
Novel Single Chain Trispecific Immunotoxin D2C7-Mel-14 for GBM Therapy | |
|
|
07/21/2010 $50,000.00 |
|
|
|
|
|
|||||||||
|
Analysis of brain tumor virtual trial data | |
|
|
12/30/2009 $5,000.00 |
|
|
|
|
|
|||||||||
|
Chemoradiotherapy of High Grade Gliomas Using Convection Enhanced Delivery of Carboplatin in Combination with X-irradiation | |
|
|
12/30/2009 $50,000.00 |
|
|
|
|
|
|||||||||
|
Targeting Metabolism in Brain Tumors | |
|
|
12/30/2009 $50,000.00 |
|
|
|
|
|
|||||||||
|
Pediatric Brain Tumor Research at Children's Hospital, LA | |
|
|
11/25/2009 $10,000.00 |
|
|
|
|
|
|||||||||
|
Bone Morphogenetic Protein + Avastin in the Treatment of Glial Tumors | |
|
|
07/09/2009 $40,000.00 |
|
|
|
|
|
|||||||||
|
Bone Morphogenetic Protein in the Treatment of Glial Tumors | |
|
|
05/11/2009 $10,000.00 |
|
|
|
|
|
|||||||||
|
Treating Brain tumors with lnterlaced Carbon Microbeams | |
|
|
04/16/2009 $70,000.00 |
|
|
|
|
|
|||||||||
|
The role of glial fate determinants in the generation of astrocytomas | |
|
|
04/09/2009 $40,000.00 |
|
|
|
|
|
|||||||||
|
Preclinical Studies on Convection Enhanced Delivery of Carbolatin in Comination with Photon Irradiation for the Treatment of Gliomas | |
|
|
03/20/2009 $45,000.00 |
|
|
|
|
|
|||||||||
|
Combined Anti-Angiogenic and Anti-Invasive Therapy for Gliomas | |
|
|
01/04/2009 $50,000.00 |
|
|
|
|
|
|||||||||
|
Dendriatic Cell Vaccine Trial Expansion to Pediatrics | |
|
|
11/24/2008 $69,000.00 of $200,000.00 |
|
|
|
|
|
|||||||||
|
A placebo-controlled in vivo study investigating the effects of Ruta 6/Calc Phos on tumor growth and survival in rats | |
|
|
07/21/2008 $10,000.00 |
|
|
|
|
|
|||||||||
|
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Adults with WHO Grade II Gliomas | |
|
|
07/08/2008 $60,000.00 |
|
|
|
|
|
|||||||||
|
A novel pan PI3-kinase inhibitor (SF1126) in the treatment of medulloblastoma | |
|
|
05/15/2008 $20,000.00 |
|
|
|
|
|
|||||||||